A mitochondrial amidoxime-reducing component 1 (mARC1) A168T amino acid substitution does not confer protection from MASH and fibrosis in multiple mouse models of chronic liver disease
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a disorder characterized by anomalous hepatic fat accumulation and one of the leading causes of chronic liver disease. Recent genome-wide association studies identified a missense variant (p.A... ...
